SCHEMBL13662001

SCHEMBL13662001

CB(O)N1C[C@H](NS(=O)(=O)c2cc(Cl)ccc2Cl)C[C@@H]1CN1C(=O)c2ccccc2C1=O

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
HTR6 P50406 1/20 0.35
ACLY P53396 1/20 0.35
CPT2 P23786 1/20 0.34
CPT1A P50416 1/20 0.34
CPT1B Q92523 1/20 0.34
RORC P51449 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
BRD4 O60885 1/20 0.33
PSMB5 P28074 1/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3950906 0.84 ACLY (0.38) F10HSP90AA1HSP90AB1ACLYCPT2
SCHEMBL13661907 0.83 MMP2 (0.37) ALDH1A1KDM4EBRD4TSHRNPSR1
SCHEMBL13662011 0.83 HTR6 (0.41) HTR6ACLYALDH1A1KDM4EPSMB5
SCHEMBL13661984 0.83 CTSL (0.46) RORCALDH1A1BRD4
SCHEMBL13661935 0.81 HTR6 (0.38) HTR6CPT2CPT1ACPT1BALDH1A1
SCHEMBL13661942 0.81 CPT2 (0.45) HTR6ACLYCPT2CPT1ACPT1B
SCHEMBL8049539 0.81 BRD4 (0.44) F10HSP90AA1HSP90AB1CPT2CPT1A
SCHEMBL13661920 0.79 ACHE (0.43) HTR6ACLYALDH1A1KDM4ETSHR
SCHEMBL13661951 0.78 MAPT (0.36) HTR6CPT2CPT1ACPT1BALDH1A1
SCHEMBL13662004 0.76 CPT2 (0.47) CPT2CPT1ACPT1BBRD4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264431-A1 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE GLAXO GROUP LIMITED (GB) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264431-A1 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE CTSB, CTSS, CTSF F10 928/4885HSP90AA1 1841/4885HSP90AB1 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.